Search
chronic renal failure stage 4
Management:
- ACE inhibitor or ARB delays progression to ESRD relative to calcium channel blocker (35% vs 39%) [2]
- ACE inhibitor or ARB delays progression to ESRD but not mortality [3]
Related
end-stage renal disease (ESRD)
General
chronic renal failure (CRF)
References
- Centers for Disease Control and Prevention (CDC)
Chronic Kidney Disease (CKD) Surveillance Project
https://nccd.cdc.gov/ckd/Help.aspx?section=F#3
- Fu EL et al.
Comparative effectiveness of renin-angiotensin system inhibitors
and calcium channel blockers in individuals with advanced CKD:
A nationwide observational cohort study.
Am J Kidney Dis 2021 May; 77:719.
PMID: 33246024 Free article
https://www.ajkd.org/article/S0272-6386(20)31121-5/fulltext
- Ku E, Inker LA, Tighiouart H et al.
Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers for
Advanced Chronic Kidney Disease : A Systematic Review and Retrospective Individual
Participant-Level Meta-analysis of Clinical Trials.
Ann Intern Med. 2024. July 2
PMID: 38950402 Review.
https://www.acpjournals.org/doi/10.7326/M23-3236